Ruchi Patel, Rutgers Health expert, about her study showing GLP-1 is associated with lower asthma exacerbation risk, even in patients without diabetes
As research progresses, optimizing treatment protocols, exploring synergistic combinations, and harnessing biomarker-driven patient selection strategies hold immense promise
Novo Nordisk spent $7.6 million lobbying Congress over the past 12 months, and lobbying disclosures show that most of that was to promote bills in the House and Senate to expand use of the GLP-1 drugs
Most patients maintain results effectively through a combination of the following: Monthly or bi-monthly maintenance IV sessions as recommended by your dermatologist Daily use of SPF 3050 broad-spectrum sunscreen - this is non-negotiable
F., Ruschitzka, F., & Muller-Wieland, D